| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2808f5779912ea7fdb826981e34ce015 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2502-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-12 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-069
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0605
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-56966
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5073
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0607
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0634
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-12 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C40B50-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 |
| filingDate |
2010-07-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_81f93abdb82abebd9dc237c3714fb0d6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f6a8d8c05fac03d0c1f6614e6146e7a8 |
| publicationDate |
2011-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2011020293-A1 |
| titleOfInvention |
Use of Stem Cells to Reduce Leukocyte Extravasation |
| abstract |
The invention is generally directed to reducing inflammation by means of cells that secrete factors that reduce leukocyte extravasation. Specifically, the invention is directed to methods using cells that secrete factors that downregulate the expression of cellular adhesion molecules in vascular endothelial cells. Downregulating expression of cellular adhesion molecules reduces leukocyte adhesion to the endothelial cells such that extravasation is reduced. The end result is a reduction of inflammation. The cells are non-embryonic non-germ cells that have pluripotent characteristics. These may include expression of pluripotential markers and broad differentiation potential. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2013129686-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11305035-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101955053-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10531957-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20140089310-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9352003-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9861660-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8883210-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10967006-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11596517-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011212069-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9937208-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013123084-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2016282336-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10758570-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102073530-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10130736-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11071752-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20190026038-A |
| priorityDate |
2009-07-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |